>
pdufa.bio
CalendarDecisionsReadoutsPatents
Drug IndexStocksScreenerConferencesAdvisory Committees
StudiesRun-up by YearLearnGlossaryMethodologyAPIAccount
Pro

177Lu-TLX591

Updated ยทnext FDA decision on the calendar

177Lu-TLX591 is a Telix Pharmaceuticals Limited program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

TLX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Telix Pharmaceuticals Limited (TLX). We track 7 catalyst events for this program: 6 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2026TLXReadout · Nov 2026TLXReadout · Apr 2027TLXReadout · Jul 2027TLXReadout · Aug 2027TLXReadout · Oct 2027TLXReadout · Dec 2027TLX

Questions

When is 177Lu-TLX591's next FDA decision or readout?

The next tracked catalyst for 177Lu-TLX591 is a Readout in Nov 2026.

What happened at 177Lu-TLX591's most recent FDA decision?

No FDA decision for 177Lu-TLX591 is in our archive yet.

Who makes 177Lu-TLX591?

Telix Pharmaceuticals Limited (TLX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.

Facts and dates only; not investment advice. Verify against primary FDA, SEC and company filings. pdufa.bio is not affiliated with the FDA.
About · Corrections · Methodology

Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.

Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.

© 2026 pdufa.bio. All rights reserved.